ABOS News and Press, Acumen Pharmaceuticals Inc. From 11/01/22

CHARLOTTESVILLE, Va. and CARMEL, Ind., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) today announced that it published its development rationale and clinical development plan for ACU193, the first clinical-stage monoclonal antibody that selectively target...

Acumen Pharmaceuticals ( NASDAQ: ABOS ) said on Monday its monoclonal antibody, ACU193, that targets toxic soluble amyloid beta oligomers to treat early Alzheimer’s disease has been  granted fast track designation by the U.S. Food and Drug A...

CHARLOTTESVILLE, Va. and CARMEL, Ind., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) today announced that ACU193, the first clinical-stage monoclonal antibody that selectively targets toxic soluble amyloid beta oligomers (AβOs), has been granted Fa...

Summary Acumen has ACU193, an anti-amyloid oligomer antibody and its only drug candidate, in a Phase 1 trial. The Eisai news on lecanemab led to Acumen’s share price more than doubling. ACU193's mechanism of action builds on scientific publications identifying amyloid o...

The shares of microcap biotech Acumen Pharmaceuticals, Inc. ( NASDAQ: ABOS ) more than doubled in value on Wednesday after its rivals Biogen ( BIIB ) and Eisai ( OTCPK:ESALF ) ( OTCPK:ESALY ) announced promising late-stage data for experimental Alzheimer's therapy,...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Atthapon Raksthaput / Shutterstock.com Prothena (NASDAQ: PRTA ) stock is seeing massive gains on Wednesday despite a lack of news from the late-stage clinical company. However, there is news from Biog...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: pathdoc / Shutterstock.com Acumen Pharmaceuticals (NASDAQ: ABOS ) stock is rocketing higher on Wednesday but it’s not due to any news from the company. Instead, investors have Biogen  (NAS...

Why Are Alzheimer’s Stocks Up Today? This article discusses a handful of penny stocks with exposure to potential Alzheimer’s disease treatments. The bullish sympathy trend has come to light following late-breaking news on Tuesday that Biogen (NASDAQ: BIIB )...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we check out what’s going on on Wednesday morning. Moving shares this morning are clinical trial...

Image source: The Motley Fool. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q2 2022 Earnings Call Aug 15, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Tran...